Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir

Younossi ZM, Stepanova M, Afdhal NH, Kowdley KV, Zeuzem S, Henry L, et al. Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir. J Hepatol. 2015;63(2):337-345.

Publication Type:

Journal Article

Authors:

Z M Younossi; Stepanova, M.; N H Afdhal; Kowdley, K.V.; Stefan Zeuzem; Henry, L.; Hunt, S.L.; P. Marcellin

Source:

J Hepatol, Volume 63, Issue 2, p.337-345 (2015)

Keywords:

analysis, Biopsy, Boston, clinical trial, Clinical Trials, Disease, eradication, Fibrosis, France, Germany, HCV, Health, hepatitis, Hepatitis C, Israel, Life, Liver, Liver Diseases, Medicine, methods, Multivariate Analysis, Patients, Quality of Life, Questionnaires, Research, Research Support, Safety, sofosbuvir, sustained virologic response, treatment, United States, Universities, Washington, Work

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/25795586

Export Citation:

RIS Format

Top